Gossamer Bio: Pay

Gossamer Bio paid its 3 named executives $4.7M in total in FY2025 (Dec). CEO Faheem Hasnain was paid $2.3M of that.

Pay$100 in the stock at the end of FY21 → $27
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Faheem HasnainChairman, President and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
Bryan GiraudoChief Operating Officer and Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
Robert SmithChief Commercial Officer
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $3.5M. The CEO of Gossamer Bio was paid $2.3M, 35% below the median.

  1. 1Anaptysbio
  2. 2Trevi Therapeutics
  3. 3Annexon
  4. 4aTYR Pharma
  5. 5Atea Pharmaceuticals
  6. 6Fulcrum Therapeutics
  7. 7Gossamer Bio
  8. 8ACELYRINNot disclosed
  9. 9AlectorNot disclosed
  10. 10AllakosNot disclosed
  11. 11AlloVirNot disclosed
  12. 12Allogene TherapeuticsNot disclosed
  13. 13ErascaNot disclosed
  14. 14Kodiak SciencesNot disclosed
  15. 15Mersana TherapeuticsNot disclosed
  16. 16Mineralys TherapeuticsNot disclosed
  17. 17Poseida TherapeuticsNot disclosed
  18. 18RAPT TherapeuticsNot disclosed
  19. 19Ventyx BiosciencesNot disclosed
  20. 20Zentalis PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.